Alternative energy provides potential for growth

'Israel is the lab for the world.'

November 9, 2006 23:15
2 minute read.
Alternative energy provides potential for growth

solar 88. (photo credit: )


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


Israeli innovation and foreign need are creating the potential for significant growth in the underdeveloped sector of alternative energy and the government is ready to help. "The opportunity Israel presents is in the technology side … it has the ability to produce technology to go out to the world," said Dave Ronn a partner at the Houston-based law firm Mayer Brown Rowe & Maw, the eighth-largest law firm in the world. Peter del Vecchio, a partner at the same firm, said Israel should view itself as the lab for the world. The legal duo were in Israel for the Renewable and Alternative Energy Conference, which took place this week in Tel Aviv. The lawyers, whose practices focus on energy-related work, see great potential for collaboration between US oil companies and Israeli innovators. "The oil companies need diversity in their energy sources, they can no longer be beholden to one energy source. The big companies are no longer just oil companies they are energy companies," del Vecchio said. "Alternative energy is no longer a fringe issue in the US, it's an apple pie issue, it's mainstream." Ronn sees Israel as the ideal place for alternative energy development, citing a dearth of natural resources, lots of brain power and a government that wants to support it as a confluence of factors that creates this environment. "We need to tie developments of public sector and private initiatives and take advantage of capabilities already existent in Israel," said Hezi Kugler, director general of the Ministry of National Infrastructure. The private sector is "lagging behind," but the Ministry of National Infrastructure is trying to change this through an ambitious regime of incentive programs to encourage the private sector to enter the market. Through tax breaks and other economic programs, such as allowing higher prices to be paid to producers of electricity using alternative sources, the government hopes to encourage private development. A further stimulant for energy development in Israel comes from the Ministry of Science, Culture, and Sports. Dr. Eli Opper, the chief scientist at the ministry, in his address at the conference, asked "How will the Israeli economy benefit from the energy sector?" R&D, he answered, is the only chance that Israel has to prevail in the next generation because it is not excelling in renewable energy developments." But Opper wants this to change: "The area of energy is so huge, we need to expand." According to Opper, the way to achieve this is by supporting research and development, which will result in innovation. "Innovation, he said, is the way to transfer R&D into money."

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection